QCM
KRRO icon

Quantinno Capital Management’s Korro Bio KRRO Stock Holding History

Quantinno Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$407K Buy
35,978
+8,381
+30% +$92.3K ﹤0.01% 2850
2025
Q4 		$221K Buy
27,597
+21,454
+349% +$502K ﹤0.01% 3013
2025
Q3 		$294K Buy
+6,143
New +$136K ﹤0.01% 2471

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Quantinno Capital Management's KRRO Position: Q1 2026 in Review

Quantinno Capital Management increased its Korro Bio (KRRO) stake by 30% in Q1 2026, buying an estimated $92.3K and bringing the position to 35,978 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #2850.

Quantinno Capital Management first reported a position in KRRO in Q3 2025 and has held it in 3 quarters since. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Quantinno Capital Management held 35,978 shares of Korro Bio worth $407K as of Q1 2026.
  • Quantinno Capital Management bought 8,381 Korro Bio shares in Q1 2026, an estimated $92.3K.
  • Korro Bio made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2850 holding.
  • Quantinno Capital Management first reported a position in Korro Bio in Q3 2025 and has held it in 3 quarters since.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.